MICROVASCULAR THROMBOSIS

Clinical trials for MICROVASCULAR THROMBOSIS explained in plain language.

Never miss a new study

Get alerted when new MICROVASCULAR THROMBOSIS trials appear

Sign up with your email to follow new studies for MICROVASCULAR THROMBOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Brain fog breakthrough? NIH tests IV drip for long COVID

Symptom relief ENROLLING_BY_INVITATION

This study is testing if a treatment called intravenous immunoglobulin (IVIG) can help reduce neurological symptoms in people with Long COVID, such as brain fog, dizziness, and fatigue. About 45 adults who had COVID-19 at least 12 weeks ago and still have these symptoms will rece…

Matched conditions: MICROVASCULAR THROMBOSIS

Phase: PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Symptom relief

Last updated Mar 17, 2026 13:09 UTC

MICROVASCULAR THROMBOSIS

Get alerted when new MICROVASCULAR THROMBOSIS trials appear

Brain fog breakthrough? NIH tests IV drip for long COVID